Novartis Investigative Site

Pelhřimov 393 38

0 studies enrolling now · 1 studies all time

What they study most

Leukaemia, Lymphocytic, Chronic

Studies at this site

• Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy — Stopped early